AI Optics Transforming Point-of-Care Diagnostics with AI

What is AI Optics?

AI Optics has developed innovative handheld imaging technology combined with AI-based disease screening software modules to revolutionize eye care diagnostics. Their FDA-cleared Sentinel Camera captures digital images of the human eye, while their upcoming Sentinel Pro system is designed to identify and diagnose various retinal conditions including Diabetic Retinopathy, Age-Related Macular Degeneration (AMD), and Glaucoma.

The company's mission addresses the critical challenge of limited access to specialist eye care by providing simple, implementable, and cost-effective diagnostic solutions. Their technology aims to bridge the gap between primary care and specialist assessment, making comprehensive eye screening available to more patients.

Features

FDA-cleared Imaging Hardware: Proprietary optical technology for eye imaging
AI-Based Screening: Automated detection of multiple retinal diseases
Portable Design: Handheld device for flexible point-of-care use
Multi-condition Detection: Screens for diabetic retinopathy, AMD, and glaucoma

Use Cases

Primary care eye disease screening
Optometry practices
Retail health clinics
Long-term care facilities
Home health services
Health system diagnostic services

FAQs

Is the Sentinel Camera FDA-cleared?

Yes, the Sentinel Camera is FDA-cleared for capturing digital images of the human eye.
What conditions can Sentinel Pro detect?

Sentinel Pro is designed to identify and diagnose various retinal diseases, including Diabetic Retinopathy, Age-Related Macular Degeneration (AMD), and Glaucoma.
Is Sentinel Pro FDA-cleared?

No, Sentinel Pro is not FDA-cleared and is currently only intended for investigational use.